Latest filing published 23 Mar 2026 for Structure Therapeutics Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ashley Hall is a declared insider at 2 companies; the most frequent names are Structure Therapeutics Inc. and OnKure Therapeutics, Inc. Over a trading history stretching from 12 November 2021 to 19 March 2026, the count stands at 7 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 23 March 2026 came the latest disclosure, a share grant in Structure Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations